Association Between County-Level Social Vulnerability and CDC-funded HIV Testing Program Outcomes in the United States, 2020-2022.

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Wei Song, Mesfin S Mulatu, Nicole Crepaz, Guoshen Wang, Deesha Patel, Mingjing Xia, Aba Essuon
{"title":"Association Between County-Level Social Vulnerability and CDC-funded HIV Testing Program Outcomes in the United States, 2020-2022.","authors":"Wei Song, Mesfin S Mulatu, Nicole Crepaz, Guoshen Wang, Deesha Patel, Mingjing Xia, Aba Essuon","doi":"10.1097/QAI.0000000000003603","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Community-level social vulnerabilities may affect HIV outcomes. This analysis assessed the association between county-level social vulnerability and CDC-funded HIV testing program outcomes.</p><p><strong>Setting: </strong>HIV testing data from 60 state and local health departments and 119 community-based organizations were submitted to CDC during 2020-2022.</p><p><strong>Methods: </strong>HIV testing data were combined with county-level Minority Health Social Vulnerability Index, which measures economic, medical, and social vulnerability. We calculated absolute and relative disparity measures for HIV testing program outcomes (i.e., HIV positivity, linkage to medical care, interview for partner services, referral to PrEP providers) between high and low social vulnerability counties. We compared differences in HIV testing program outcomes by demographic factors and test site type.</p><p><strong>Results: </strong>The majority (85.8%) of the 4.9 million tests were conducted in high social vulnerability counties. HIV positivity (1.1%) and linkage to medical care after a new diagnosis (77.5%) were higher in high social vulnerability counties. However, interview for partner services after a new diagnosis (72.1%) and referrals to PrEP providers among eligible HIV-negative persons (48.1%) were lower in high social vulnerability counties. Additionally, the relative disparity in HIV testing program outcomes varied by demographic factors and test site type.</p><p><strong>Conclusion: </strong>CDC-funded HIV testing programs reach the most vulnerable communities. However, testing outcomes vary by community vulnerability, demographic factors, and test site type. Continued monitoring of the relationship between county-level social vulnerability and HIV testing program outcomes would guide HIV testing efforts and allocate resources effectively to achieve the national goal of ending the HIV epidemic.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003603","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Community-level social vulnerabilities may affect HIV outcomes. This analysis assessed the association between county-level social vulnerability and CDC-funded HIV testing program outcomes.

Setting: HIV testing data from 60 state and local health departments and 119 community-based organizations were submitted to CDC during 2020-2022.

Methods: HIV testing data were combined with county-level Minority Health Social Vulnerability Index, which measures economic, medical, and social vulnerability. We calculated absolute and relative disparity measures for HIV testing program outcomes (i.e., HIV positivity, linkage to medical care, interview for partner services, referral to PrEP providers) between high and low social vulnerability counties. We compared differences in HIV testing program outcomes by demographic factors and test site type.

Results: The majority (85.8%) of the 4.9 million tests were conducted in high social vulnerability counties. HIV positivity (1.1%) and linkage to medical care after a new diagnosis (77.5%) were higher in high social vulnerability counties. However, interview for partner services after a new diagnosis (72.1%) and referrals to PrEP providers among eligible HIV-negative persons (48.1%) were lower in high social vulnerability counties. Additionally, the relative disparity in HIV testing program outcomes varied by demographic factors and test site type.

Conclusion: CDC-funded HIV testing programs reach the most vulnerable communities. However, testing outcomes vary by community vulnerability, demographic factors, and test site type. Continued monitoring of the relationship between county-level social vulnerability and HIV testing program outcomes would guide HIV testing efforts and allocate resources effectively to achieve the national goal of ending the HIV epidemic.

2020-2022年美国县级社会脆弱性与cdc资助的HIV检测项目结果之间的关系
背景:社区层面的社会脆弱性可能影响艾滋病毒的结局。该分析评估了县级社会脆弱性与cdc资助的HIV检测项目结果之间的关系。环境:来自60个州和地方卫生部门以及119个社区组织的艾滋病毒检测数据在2020-2022年期间提交给疾病预防控制中心。方法:将HIV检测数据与县级少数民族健康社会脆弱性指数相结合,该指数衡量经济、医疗和社会脆弱性。我们计算了高易损性县和低易损性县之间艾滋病毒检测项目结果(即艾滋病毒阳性,与医疗保健的联系,合作伙伴服务的访谈,转介给PrEP提供者)的绝对和相对差异措施。我们比较了人口因素和检测地点类型在HIV检测项目结果上的差异。结果:490万次检测中,绝大多数(85.8%)是在社会脆弱性高的县进行的。在高社会脆弱性县,艾滋病毒阳性(1.1%)和新诊断后的医疗联系(77.5%)较高。然而,在高社会脆弱性县,在新诊断后接受伴侣服务的访谈(72.1%)和在符合条件的艾滋病毒阴性者中转诊到PrEP提供者(48.1%)的比例较低。此外,艾滋病毒检测项目结果的相对差异因人口因素和检测地点类型而异。结论:疾控中心资助的艾滋病毒检测项目覆盖了最脆弱的社区。然而,测试结果因社区脆弱性、人口因素和测试地点类型而异。继续监测县级社会脆弱性与艾滋病毒检测方案成果之间的关系,将指导艾滋病毒检测工作,并有效分配资源,以实现结束艾滋病毒流行的国家目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信